{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:46:07Z","timestamp":1762501567170,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07781"],"award-info":[{"award-number":["19K07781"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","award":["2019-36","30\u201352"],"award-info":[{"award-number":["2019-36","30\u201352"]}],"id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bbrep.2021.101089","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T06:28:58Z","timestamp":1627453738000},"page":"101089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SCLC-J1, a novel small cell lung cancer cell line"],"prefix":"10.1016","volume":"27","author":[{"given":"Kazuo","family":"Ohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Azusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-6653","authenticated-orcid":false,"given":"Yoichiro","family":"Mitsuishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9975-2282","authenticated-orcid":false,"given":"Tetsuhiko","family":"Asao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketsugu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-4118","authenticated-orcid":false,"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-1330","authenticated-orcid":false,"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9804","key":"10.1016\/j.bbrep.2021.101089_bib1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbrep.2021.101089_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1 Suppl","key":"10.1016\/j.bbrep.2021.101089_bib3","article-title":"Small cell lung cancer","volume":"123","author":"Simon","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Canc."},{"issue":"10212","key":"10.1016\/j.bbrep.2021.101089_bib5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bbrep.2021.101089_bib6","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-14-2958","article-title":"Small cell lung cancer: will recent progress lead to improved outcomes?","volume":"21","author":"Pietanza","year":"2015","journal-title":"Clin. Canc. Res."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101089_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/JTO.0000000000000142","article-title":"Small-cell lung cancers in patients who never smoked cigarettes","volume":"9","author":"Varghese","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbrep.2021.101089_bib8","first-page":"423","article-title":"Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer","volume":"1","author":"Stewart","year":"2020","journal-title":"Nat. Can. (Que.)"},{"issue":"4","key":"10.1016\/j.bbrep.2021.101089_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(19)30043-8","article-title":"Immune checkpoint inhibitors in non-small-cell lung cancer: key to long-term survival?","volume":"7","author":"Dingemans","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.bbrep.2021.101089_bib10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/bioinformatics\/btu862","article-title":"DDIG-in: detecting disease-causing genetic variations due to frameshifting indels and nonsense mutations employing sequence and structural properties at nucleotide and protein levels","volume":"31","author":"Folkman","year":"2015","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.bbrep.2021.101089_bib11","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bbrep.2021.101089_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2478\/v10042-009-0018-y","article-title":"Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component","volume":"47","author":"Skirecki","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101089_bib13","first-page":"2913","article-title":"Establishment and identification of small cell lung cancer cell lines having classic and variant features","volume":"45","author":"Carney","year":"1985","journal-title":"Canc. Res."},{"issue":"7463","key":"10.1016\/j.bbrep.2021.101089_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bbrep.2021.101089_bib15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41571-019-0316-z","article-title":"Immunotherapeutic approaches for small-cell lung cancer","volume":"17","author":"Iams","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2021.101089_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fonc.2020.01000","article-title":"Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy","volume":"10","author":"Nazha","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.bbrep.2021.101089_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2011.90","article-title":"Novel strategies for the treatment of small-cell lung carcinoma","volume":"8","author":"William","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.bbrep.2021.101089_bib19","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1182\/blood-2011-05-354449","article-title":"Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma","volume":"118","author":"Louis","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbrep.2021.101089_bib20","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ymthe.2017.05.012","article-title":"CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma","volume":"25","author":"Heczey","year":"2017","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101089_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1083\/jcb.200503113","article-title":"The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands","volume":"170","author":"Ladi","year":"2005","journal-title":"J. Cell Biol."},{"issue":"6627","key":"10.1016\/j.bbrep.2021.101089_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/386852a0","article-title":"An achaete-scute homologue essential for neuroendocrine differentiation in the lung","volume":"386","author":"Borges","year":"1997","journal-title":"Nature"},{"issue":"302","key":"10.1016\/j.bbrep.2021.101089_bib23","doi-asserted-by":"crossref","first-page":"302ra136","DOI":"10.1126\/scitranslmed.aac9459","article-title":"A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo","volume":"7","author":"Saunders","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2021.101089_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1470-2045(16)30565-4","article-title":"Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study","volume":"18","author":"Rudin","year":"2017","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1078-0432.CCR-20-2845","article-title":"AMG 757, a half-life extended, DLL3-targeted bispecific T-cell engager, shows high potency and sensitivity in preclinical models of small-cell lung cancer","volume":"27","author":"Giffin","year":"2021","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.bbrep.2021.101089_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0745-2","article-title":"DLL3: an emerging target in small cell lung cancer","volume":"12","author":"Owen","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bbrep.2021.101089_bib27","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.172.4.2352","article-title":"Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains","volume":"172","author":"Steinberger","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","article-title":"B7-H3: an attractive target for antibody-based immunotherapy","volume":"27","author":"Kontos","year":"2021","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrep.2021.101089_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ebiom.2019.08.030","article-title":"B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres","volume":"47","author":"Nehama","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bbrep.2021.101089_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-019-0540-1","article-title":"Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)","volume":"7","author":"Carvajal-Hausdorf","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"7563","key":"10.1016\/j.bbrep.2021.101089_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","article-title":"Modular organization and assembly of SWI\/SNF family chromatin remodeling complexes","volume":"175","author":"Mashtalir","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbrep.2021.101089_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbrep.2021.101089_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrc.2017.106","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nat. Rev. Canc."},{"issue":"8","key":"10.1016\/j.bbrep.2021.101089_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071670","article-title":"Genomic deregulation of the E2F\/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer","volume":"8","author":"Coe","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.bbrep.2021.101089_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","article-title":"Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis","volume":"31","author":"Gardner","year":"2017","journal-title":"Canc. Cell"},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050690","article-title":"Future options of molecular-targeted therapy in small cell lung cancer","volume":"11","author":"Schulze","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bbrep.2021.101089_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ymthe.2019.02.014","article-title":"EZH2 Inhibition in Ewing sarcoma upregulates GD2 expression for targeting with gene-modified T cells","volume":"27","author":"Kailayangiri","year":"2019","journal-title":"Mol. Ther."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:43:28Z","timestamp":1762501408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580821001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"alternative-id":["S2405580821001837"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101089","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCLC-J1, a novel small cell lung cancer cell line","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Juntendo University School of Medicine. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101089"}}